Eurizon Capital SGR SpA’s Zymeworks ZYME Stock Holding History

Eurizon Capital SGR SpA’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$31.9K	Buy	+1,321	New	+$33.6K	﹤0.01%	1093

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Eurizon Capital SGR SpA's ZYME Position: Q2 2026 in Review

Eurizon Capital SGR SpA opened a new position in Zymeworks (ZYME) in Q2 2026: 1,321 shares worth $31.9K. The stake represents ﹤0.01% of the portfolio and ranks #1093 among its holdings.

202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Eurizon Capital SGR SpA held 1,321 shares of Zymeworks worth $31.9K as of Q2 2026.
Zymeworks was a new Eurizon Capital SGR SpA position in Q2 2026.
Zymeworks made up ﹤0.01% of Eurizon Capital SGR SpA's portfolio in Q2 2026, its #1093 holding.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Eurizon Capital SGR SpA's 13F filing for Q2 2026, filed 29 Jul 2026.